Found: 253
Select item for more details and to access through your institution.
Passive immunotherapies for the next influenza pandemic.
- Published in:
- Reviews in Medical Virology, 2024, v. 34, n. 3, p. 1, doi. 10.1002/rmv.2533
- By:
- Publication type:
- Article
Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis.
- Published in:
- Diseases, 2024, v. 12, n. 3, p. 41, doi. 10.3390/diseases12030041
- By:
- Publication type:
- Article
Late Administration and Corticosteroid Usage Explain Inefficacy in COVID-19 Convalescent Plasma Trial.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 2, p. 617, doi. 10.1093/infdis/jiad509
- By:
- Publication type:
- Article
Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Transfusion, 2024, v. 64, n. 2, p. 388, doi. 10.1111/trf.17701
- By:
- Publication type:
- Article
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 217, doi. 10.3390/v16020217
- By:
- Publication type:
- Article
Outpatient randomized controlled trials to reduce COVID‐19 hospitalization: Systematic review and meta‐analysis.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 12, p. 1, doi. 10.1002/jmv.29310
- By:
- Publication type:
- Article
Convalescent Plasma Versus Hyperimmune Immunoglobulins.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Disaster mycology.
- Published in:
- Biomédica: Revista del Instituto Nacional de Salud, 2023, v. 43, p. 267, doi. 10.7705/biomedica.6943
- By:
- Publication type:
- Article
The emergency use authorization for COVID‐19 convalescent plasma reduced mortality.
- Published in:
- Health Science Reports, 2023, v. 6, n. 8, p. 1, doi. 10.1002/hsr2.1463
- By:
- Publication type:
- Article
Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data From the National Inpatient Sample.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 2, p. 237, doi. 10.1093/cid/ciad185
- By:
- Publication type:
- Article
Misinterpretation of Clinical Research Findings and COVID-19 Mortality.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 7, p. 993, doi. 10.7326/M23-0737
- By:
- Publication type:
- Article
Cuticular profiling of insecticide resistant Aedes aegypti.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36926-3
- By:
- Publication type:
- Article
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 2018, doi. 10.1093/cid/ciad066
- By:
- Publication type:
- Article
Weaponising microbes for peace.
- Published in:
- Microbial Biotechnology, 2023, v. 16, n. 6, p. 1091, doi. 10.1111/1751-7915.14224
- By:
- Publication type:
- Article
Outpatient Treatment of Confirmed COVID-19.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 5, p. 1, doi. 10.7326/L23-0099
- By:
- Publication type:
- Article
Correction: On the relationship between Pathogenic Potential and Infective Inoculum.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Reciprocal modulation of ammonia and melanin production has implications for cryptococcal virulence.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36552-7
- By:
- Publication type:
- Article
Recent Hybrid Plasma Better Neutralizes Omicron Sublineages Than Old Hyperimmune Serum.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e477, doi. 10.1093/cid/ciac372
- By:
- Publication type:
- Article
Convalescent plasma in oncohematological patients.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 208, doi. 10.1002/hon.3069
- By:
- Publication type:
- Article
Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2264, doi. 10.3390/ijms24032264
- By:
- Publication type:
- Article
Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 2, p. e22, doi. 10.1111/bjh.18544
- By:
- Publication type:
- Article
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2250647, doi. 10.1001/jamanetworkopen.2022.50647
- By:
- Publication type:
- Article
Last but not yeast—The many forms of Cryptococcus neoformans.
- Published in:
- PLoS Pathogens, 2023, v. 18, n. 1, p. 1, doi. 10.1371/journal.ppat.1011048
- By:
- Publication type:
- Article
Discriminating endogenous vaccine‐elicited anti‐Spike antibody responses from exogenous anti‐Spike monoclonal antibodies: The case of Evusheld.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28277
- By:
- Publication type:
- Article
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
- Published in:
- Life (2075-1729), 2023, v. 13, n. 1, p. 134, doi. 10.3390/life13010134
- By:
- Publication type:
- Article
Absence of pathogenic viruses in COVID‐19 convalescent plasma.
- Published in:
- Transfusion, 2023, v. 63, n. 1, p. 23, doi. 10.1111/trf.17168
- By:
- Publication type:
- Article
Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS‐CoV‐2 in a US‐like population.
- Published in:
- Transfusion, 2023, v. 63, n. 1, p. 92, doi. 10.1111/trf.17174
- By:
- Publication type:
- Article
Galleria mellonella immune melanization is fungicidal during infection.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04340-6
- By:
- Publication type:
- Article
On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2378, doi. 10.3390/v14112378
- By:
- Publication type:
- Article
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33864-y
- By:
- Publication type:
- Article
Melanization of Candida auris Is Associated with Alteration of Extracellular pH.
- Published in:
- Journal of Fungi, 2022, v. 8, n. 10, p. 1068, doi. 10.3390/jof8101068
- By:
- Publication type:
- Article
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1310, doi. 10.7326/M22-1079
- By:
- Publication type:
- Article
Reflections after 2 years of COVID‐19 pandemic.
- Published in:
- Reviews in Medical Virology, 2022, v. 32, n. 5, p. 1, doi. 10.1002/rmv.2351
- By:
- Publication type:
- Article
A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 9, p. 1999, doi. 10.3390/v14091999
- By:
- Publication type:
- Article
Melanin protects Cryptococcus neoformans from spaceflight effects.
- Published in:
- Environmental Microbiology Reports, 2022, v. 14, n. 4, p. 679, doi. 10.1111/1758-2229.13078
- By:
- Publication type:
- Article
A practical treatment for COVID‐19 and the next pandemic.
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 4, p. 1, doi. 10.1002/prp2.988
- By:
- Publication type:
- Article
Pathogen reduction technologies need to evaluate Fc-mediated antibody functions.
- Published in:
- 2022
- By:
- Publication type:
- letter
Bet-hedging antimicrobial strategies in macrophage phagosome acidification drive the dynamics of Cryptococcus neoformans intracellular escape mechanisms.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 7, p. 1, doi. 10.1371/journal.ppat.1010697
- By:
- Publication type:
- Article
Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?
- Published in:
- Reviews in Medical Virology, 2022, v. 32, n. 4, p. 1, doi. 10.1002/rmv.2314
- By:
- Publication type:
- Article
On the relationship between Pathogenic Potential and Infective Inoculum.
- Published in:
- PLoS Pathogens, 2022, v. 18, n. 6, p. 1, doi. 10.1371/journal.ppat.1010484
- By:
- Publication type:
- Article
Fungal polysaccharides are altered by lyophilization resulting in decreased antibody binding.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R5955
- By:
- Publication type:
- Article
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
- Published in:
- 2022
- By:
- Publication type:
- letter
Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants?
- Published in:
- Vox Sanguinis, 2022, v. 117, n. 5, p. 641, doi. 10.1111/vox.13239
- By:
- Publication type:
- Article
Faster Cryptococcus Melanization Increases Virulence in Experimental and Human Cryptococcosis.
- Published in:
- Journal of Fungi, 2022, v. 8, n. 4, p. 393, doi. 10.3390/jof8040393
- By:
- Publication type:
- Article
Do individual and institutional predictors of misconduct vary by country? Results of a matched-control analysis of problematic image duplications.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0255334
- By:
- Publication type:
- Article
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2.
- Published in:
- BMC Immunology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12865-022-00480-w
- By:
- Publication type:
- Article
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 187, doi. 10.3390/v14020187
- By:
- Publication type:
- Article
Hinge influences in murine IgG binding to Cryptococcus neoformans capsule.
- Published in:
- Immunology, 2022, v. 165, n. 1, p. 110, doi. 10.1111/imm.13411
- By:
- Publication type:
- Article
Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 1, p. 29, doi. 10.3390/ijms23010029
- By:
- Publication type:
- Article